glp-1 off label A clinician's perspective π receptor agonists are primarily approved for type 2 diabetes, weight management, and cardiovascular risk reduction, but are increasingly used off-label in dermatology where metabolic dysfunction plays a Craving Reduction Comprehensive Metabolic Health Off-Label Uses for GLP-1 Drugs:
Description
A thumb-sized portion of healthy fat: extra virgin olive oil, avocado, nuts, or oily fish like salmon

New evidence shows that GLP-1based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic potential beyond metabolism

I have the drive and I have the willingness and I have the motivation, but I have not been able to lose weight in all the conventional ways.

A similar beneficial association was seen in an observational study of semaglutide in 83,825 patients with obesity and 598,803 patients with T2DM over 12 months 112 , as well as in 87,676 new users of GLP-1RAs or DPP-4 inhibitors over 4 years 113

Data availability The authors declare that all data supporting the findings of this study are available within the paper, Supplementary Information and the Source Data file
